The Phase 3 SOLO-1 trial demonstrated 67% of advanced ovarian cancer patients with BRCA mutations receiving LYNPARZA were alive at seven years versus 47% of placebo patients
Two main objectives are: Accelerate novel technologies and products for global markets; and Connect academia and industry, creating synergy for faster advancement of the Bioprotection sector
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
The existing hospital premises has the scope to further scale up the bed capacity as and when required in the future with minimal Capex.
It is high time that India assumed a leadership role in healthcare.
The initiative aims to reach out to more than 20 million people across the country and a number of social media influencers have also pledged to extend their whole-hearted support for the noble cause
3D CMOS chip for connecting electroactive tissues and organoids to software
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
Pharmaceutical sales de-grew 18% YoY and stood at Rs. 224 crore whereas Crop Protection sales de-grew by 15% at Rs. 154 crore
Sridhar will continue to serve in his current position of Managing Director for as long a period as required until the identification, selection and transition to the new leadership takes place in the company.
Subscribe To Our Newsletter & Stay Updated
